Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Idorsia Pharmaceuticals Ltd.)"
Count: 102
Selected: 0
| NCT ID | Title |
|---|
| NCT05254548 | A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects | ||
| NCT05196399 | Bioequivalence Study of Different Aprocitentan Tablet Formulations | ||
| NCT05123820 | Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470 | ||
| NCT05004311 | The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics | ||
| NCT04957719 | Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ||
| NCT04899219 | A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects | ||
| NCT04819464 | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod | ||
| NCT04798209 | A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects | ||
| NCT04753164 | Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder | ||
| NCT04608513 | A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects | ||
| NCT04557280 | A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects | ||
| NCT04470713 | Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2 | ||
| NCT04452006 | A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478 | ||
| NCT04406896 | The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics | ||
| NCT04390334 | A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant. | ||
| NCT04286750 | Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239 | ||
| NCT04281342 | To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women | ||
| NCT04255277 | To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men. | ||
| NCT04252495 | The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics | ||
| NCT04250506 | A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects | ||
| NCT04183686 | A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects | ||
| NCT04162366 | A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. | ||
| NCT04123288 | A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men | ||
| NCT04052360 | Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects | ||
| NCT04024332 | Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects | ||
| NCT03913000 | A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease | ||
| NCT03907215 | A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects | ||
| NCT03892902 | A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects | ||
| NCT03869320 | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects | ||
| NCT03832452 | A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function | ||
| NCT03814200 | A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects | ||
| NCT03799978 | A Clinical Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects | ||
| NCT03765294 | A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea | ||
| NCT03742037 | Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus | ||
| NCT03737214 | A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease | ||
| NCT03713242 | A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment | ||
| NCT03688555 | A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis | ||
| NCT03679884 | Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep | ||
| NCT03657446 | A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function | ||
| NCT03657355 | Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users | ||
| NCT03646864 | A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease | ||
| NCT03609775 | A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects | ||
| NCT03596294 | A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan | ||
| NCT03593278 | A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects | ||
| NCT03586570 | A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects | ||
| NCT03585270 | Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain | ||
| NCT03575104 | Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep | ||
| NCT03545191 | Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder | ||
| NCT03541174 | A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety | ||
| NCT03487445 | A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack |
